North American Science Associates, Inc. (NAMSA) announces a definitive agreement to divest its Sterility Assurance Products Division of biological and chemical indicators. Crosstex International, Inc., dedicated to delivering innovative infection prevention products for patients, caregivers and other healthcare providers, will acquire the assets of NAMSA’s Products business to further expand their offerings in the industrial market. The divestiture is consistent with NAMSA’s strategy to focus the organization on preclinical and clinical services that support the MRO® Approach, which offers a combination of regulatory and quality consulting, laboratory testing and clinical research to reduce time to market for its clients.
As part of Crosstex, the industrial sterilization monitoring portfolio will be well positioned to continue to grow its global leadership position. This transaction will complement the biological monitoring portfolio of Crosstex, which is currently focused in the dental and medical markets. Crosstex will provide industrial clients sterilization monitoring products with the same level of service and support that they receive from NAMSA today with an expanded product offering.
After the transaction closes, NAMSA will continue to manufacture sterilization monitoring products (for Crosstex) through the middle of 2016 depending on the product configuration, at which time Crosstex will integrate manufacturing into its global supply chain.
Subject to customary closing conditions, NAMSA (and Crosstex) expect the transaction to close in the first quarter of 2016.
Source: NAMSA
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
Infection Prevention in Low-Resource Settings: Two Infection Preventionists Consult in East Africa
January 29th 2024Infection preventionists Heather Saunders and Stephanie Mayoryk's journey to East Africa emphasizes the positive impact of infection prevention efforts in low-income countries. Despite challenges, their experience encourages IPs to engage globally, fostering hope and passion for providing excellent patient care.